<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Lindhardt Larsson | Activity</title>
	<link>http://toxicdolls.com/members/modembait7/activity/</link>
	<atom:link href="http://toxicdolls.com/members/modembait7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lindhardt Larsson.</description>
	<lastBuildDate>Sun, 08 Nov 2026 17:11:27 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b9d5cdc18d79996d350d5fa98d93e7cd</guid>
				<title>Lindhardt Larsson posted an update: 5, MIC × 1, and MIC × 2 in succession. Substantial s [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/55692/</link>
				<pubDate>Tue, 15 Jul 2025 10:16:47 +0000</pubDate>

									<content:encoded><![CDATA[<p>5, MIC × 1, and MIC × 2 in succession. Substantial suppression was also developed in the biofilm production of the investigated periodontopathic strains following exposure to numerous concentrations of </p>
<p> extract for a period of 24 and 48 h.</p>
<p> These outcomes divulge a new concept that </p>
<p> extract can be utilized to manufacture valuable a&hellip;<span class="activity-read-more" id="activity-read-more-55692"><a href="http://toxicdolls.com/activity-2/p/55692/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9b5fd577262af3ffd9af12eb872fe49f</guid>
				<title>Lindhardt Larsson posted an update: The ability of G protein-coupled receptor (GPCR) kinases [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/54169/</link>
				<pubDate>Mon, 14 Jul 2025 09:23:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>The ability of G protein-coupled receptor (GPCR) kinases (GRKs) to regulate the desensitization of GPCRs has made GRK2 and GRK5 attractive targets for treating diseases such as heart failure and cancer. Previously, our work showed that Cys474, a GRK5 subfamily-specific residue located on a flexible loop adjacent to the active site, can be used as&hellip;<span class="activity-read-more" id="activity-read-more-54169"><a href="http://toxicdolls.com/activity-2/p/54169/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7882654a42140bf494172ddee8f0938e</guid>
				<title>Lindhardt Larsson posted an update: A 63-year-old Japanese male with stomach adenocarcinoma [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/50788/</link>
				<pubDate>Sun, 13 Jul 2025 09:54:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>A 63-year-old Japanese male with stomach adenocarcinoma received oral 5-fluorouracil derivative, cisplatin and trastuzumab chemotherapy. On day 8, severe diarrhea and mucositis developed; chemotherapy was stopped. On day 14, the patient developed renal dysfunction and febrile neutropenia. He also suffered from pneumonia due to Candida albicans.&hellip;<span class="activity-read-more" id="activity-read-more-50788"><a href="http://toxicdolls.com/activity-2/p/50788/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7de3df8c2a8e8a03d3a6a294825057bd</guid>
				<title>Lindhardt Larsson posted an update: 17, 1.58; P  less then  0.001), higher intraocular pre [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/47145/</link>
				<pubDate>Sat, 12 Jul 2025 10:27:42 +0000</pubDate>

									<content:encoded><![CDATA[<p>17, 1.58; P  less then  0.001), higher intraocular pressure (IOP) (OR 1.18; 95% CI 1.13, 1.23; P  less then  0.001), higher stage of lens pseudoexfoliation (OR 1.26; 95% CI 1.08, 1.47; P = 0.004) and lower diastolic blood pressure (OR 0.98; 95% CI 0.96, 0.99; P = 0.035). Higher ACG prevalence correlated with older age (OR 1.07; 95% CI 1.03, 1.11;&hellip;<span class="activity-read-more" id="activity-read-more-47145"><a href="http://toxicdolls.com/activity-2/p/47145/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6604c34a64a2bb12ab7d6d4c8daf96ad</guid>
				<title>Lindhardt Larsson posted an update: Anti-S. aureus and anti-GBS antibody titers were compared to [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/43744/</link>
				<pubDate>Fri, 11 Jul 2025 10:16:13 +0000</pubDate>

									<content:encoded><![CDATA[<p>Anti-S. aureus and anti-GBS antibody titers were compared to culture results to assess their concordance in identifying the pathogens. Immunoassay, particularly MENSA, showed high diagnostic potential for monomicrobial S. aureus and GBS orthopedic infections (AUC &gt; 0.95). MENSA also demonstrated diagnostic potential for GBS polymicrobial ort&hellip;<span class="activity-read-more" id="activity-read-more-43744"><a href="http://toxicdolls.com/activity-2/p/43744/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">69dfc15171cc6de8e802247c66c0e8d2</guid>
				<title>Lindhardt Larsson posted an update: 5% for 14 days did not cause skin atrophy or decreased [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/40201/</link>
				<pubDate>Thu, 10 Jul 2025 08:49:43 +0000</pubDate>

									<content:encoded><![CDATA[<p>5% for 14 days did not cause skin atrophy or decreased immunohistochemical staining of epidermal claudins, which are common safety concerns associated with TCSs. These characteristics suggest that delgocitinib ointment 0.5% has an improved safety profile over currently available TCS therapies particular for the long-term AD treatment.It is well&hellip;<span class="activity-read-more" id="activity-read-more-40201"><a href="http://toxicdolls.com/activity-2/p/40201/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ab1276cfcb61d1c187db22645068b373</guid>
				<title>Lindhardt Larsson became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/40139/</link>
				<pubDate>Thu, 10 Jul 2025 08:16:10 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>